IL1F10 and colorectal carcinoma: Considering that the pathophysiological function of IL-38 is to bind via the IL-36 receptor to block IL-36 signaling (20, 67), these data are consistent with the observed correlation between high expression of IL-38 and improved 5-year survival in CRC (55).